Starting up and spinning out: The changing nature of partnerships between pharma and academia

In 2005, two chemists decided to work together to develop libraries of cyclic peptides—strings of amino acids formed in the shape of a circle—that could be used to treat a range of infectious diseases, autoimmunity and cancer. Thanks to their flexibility, these cyclic peptides can access different parts of a protein target and so bind to …

Read article at natureMedicine

2018-04-01T22:04:40+00:00 September 4th, 2015|In the News|